Recruiting
Phase 1

Allogeneic T-cell Therapy

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT04881240

Conditions

Acute Lymphoblastic Leukemia, in Relapse

Acute Lymphoblastic Leukemia, Refractory

Pediatric ALL

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Interventions

CD19-CAR(Mem) T-cells

Cyclophosphamide

Fludarabine

Mesna

CliniMACS

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information